nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Ipratropium bromide—SLC22A4—Crohn's disease	0.0157	0.571	CrCbGaD
Methylphenidate—Ipratropium bromide—SLC22A5—Crohn's disease	0.0118	0.429	CrCbGaD
Methylphenidate—Liver function test abnormal—Mesalazine—Crohn's disease	0.00358	0.00368	CcSEcCtD
Methylphenidate—Abscess—Prednisone—Crohn's disease	0.00357	0.00368	CcSEcCtD
Methylphenidate—Abdominal pain upper—Mesalazine—Crohn's disease	0.00354	0.00364	CcSEcCtD
Methylphenidate—Abdominal discomfort—Azathioprine—Crohn's disease	0.00353	0.00363	CcSEcCtD
Methylphenidate—Oedema—Mercaptopurine—Crohn's disease	0.00351	0.00361	CcSEcCtD
Methylphenidate—Breast disorder—Mesalazine—Crohn's disease	0.00351	0.00361	CcSEcCtD
Methylphenidate—Pancytopenia—Azathioprine—Crohn's disease	0.0035	0.0036	CcSEcCtD
Methylphenidate—Cramp muscle—Mesalazine—Crohn's disease	0.00349	0.00359	CcSEcCtD
Methylphenidate—Nasopharyngitis—Mesalazine—Crohn's disease	0.00347	0.00357	CcSEcCtD
Methylphenidate—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00344	0.00354	CcSEcCtD
Methylphenidate—Petechiae—Prednisone—Crohn's disease	0.00344	0.00353	CcSEcCtD
Methylphenidate—Gastritis—Mesalazine—Crohn's disease	0.00343	0.00353	CcSEcCtD
Methylphenidate—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00342	0.00352	CcSEcCtD
Methylphenidate—Skin disorder—Mercaptopurine—Crohn's disease	0.00341	0.00351	CcSEcCtD
Methylphenidate—Asthma—Mesalazine—Crohn's disease	0.00335	0.00345	CcSEcCtD
Methylphenidate—Influenza—Mesalazine—Crohn's disease	0.00335	0.00345	CcSEcCtD
Methylphenidate—Anorexia—Mercaptopurine—Crohn's disease	0.00335	0.00344	CcSEcCtD
Methylphenidate—Pneumonia—Azathioprine—Crohn's disease	0.0033	0.0034	CcSEcCtD
Methylphenidate—Delirium—Prednisone—Crohn's disease	0.00329	0.00338	CcSEcCtD
Methylphenidate—Pancreatitis—Mesalazine—Crohn's disease	0.00329	0.00338	CcSEcCtD
Methylphenidate—Infestation NOS—Azathioprine—Crohn's disease	0.00328	0.00338	CcSEcCtD
Methylphenidate—Infestation—Azathioprine—Crohn's disease	0.00328	0.00338	CcSEcCtD
Methylphenidate—Angina pectoris—Mesalazine—Crohn's disease	0.00327	0.00336	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00325	0.00335	CcSEcCtD
Methylphenidate—Contusion—Prednisone—Crohn's disease	0.00324	0.00333	CcSEcCtD
Methylphenidate—Bronchitis—Mesalazine—Crohn's disease	0.00323	0.00332	CcSEcCtD
Methylphenidate—Abdominal discomfort—Mesalazine—Crohn's disease	0.00321	0.00331	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0032	0.00329	CcSEcCtD
Methylphenidate—Pancytopenia—Mesalazine—Crohn's disease	0.00318	0.00327	CcSEcCtD
Methylphenidate—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00312	0.0032	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Azathioprine—Crohn's disease	0.0031	0.00319	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00306	0.00315	CcSEcCtD
Methylphenidate—Decreased appetite—Mercaptopurine—Crohn's disease	0.00305	0.00314	CcSEcCtD
Methylphenidate—Weight increased—Mesalazine—Crohn's disease	0.00305	0.00314	CcSEcCtD
Methylphenidate—Weight decreased—Mesalazine—Crohn's disease	0.00303	0.00312	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00303	0.00312	CcSEcCtD
Methylphenidate—Pneumonia—Mesalazine—Crohn's disease	0.00301	0.00309	CcSEcCtD
Methylphenidate—Infestation NOS—Mesalazine—Crohn's disease	0.00299	0.00307	CcSEcCtD
Methylphenidate—Infestation—Mesalazine—Crohn's disease	0.00299	0.00307	CcSEcCtD
Methylphenidate—Ulcer—Prednisone—Crohn's disease	0.00299	0.00307	CcSEcCtD
Methylphenidate—Depression—Mesalazine—Crohn's disease	0.00298	0.00307	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00296	0.00305	CcSEcCtD
Methylphenidate—Haemoglobin—Azathioprine—Crohn's disease	0.00296	0.00305	CcSEcCtD
Methylphenidate—Haemorrhage—Azathioprine—Crohn's disease	0.00295	0.00303	CcSEcCtD
Methylphenidate—Conjunctivitis—Mesalazine—Crohn's disease	0.00291	0.00299	CcSEcCtD
Methylphenidate—Vasculitis—Prednisone—Crohn's disease	0.0029	0.00298	CcSEcCtD
Methylphenidate—Sweating—Mesalazine—Crohn's disease	0.00287	0.00295	CcSEcCtD
Methylphenidate—Haematuria—Mesalazine—Crohn's disease	0.00285	0.00293	CcSEcCtD
Methylphenidate—Hiccups—Prednisone—Crohn's disease	0.00283	0.00291	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00283	0.00291	CcSEcCtD
Methylphenidate—Epistaxis—Mesalazine—Crohn's disease	0.00282	0.0029	CcSEcCtD
Methylphenidate—Sinusitis—Mesalazine—Crohn's disease	0.00281	0.00288	CcSEcCtD
Methylphenidate—Erythema multiforme—Azathioprine—Crohn's disease	0.00279	0.00286	CcSEcCtD
Methylphenidate—Body temperature increased—Mercaptopurine—Crohn's disease	0.00278	0.00286	CcSEcCtD
Methylphenidate—Skin exfoliation—Prednisone—Crohn's disease	0.0027	0.00278	CcSEcCtD
Methylphenidate—Haemoglobin—Mesalazine—Crohn's disease	0.0027	0.00277	CcSEcCtD
Methylphenidate—Rhinitis—Mesalazine—Crohn's disease	0.00269	0.00277	CcSEcCtD
Methylphenidate—Haemorrhage—Mesalazine—Crohn's disease	0.00268	0.00276	CcSEcCtD
Methylphenidate—Pharyngitis—Mesalazine—Crohn's disease	0.00266	0.00274	CcSEcCtD
Methylphenidate—Immune system disorder—Azathioprine—Crohn's disease	0.00266	0.00274	CcSEcCtD
Methylphenidate—Mediastinal disorder—Azathioprine—Crohn's disease	0.00266	0.00273	CcSEcCtD
Methylphenidate—Urinary tract disorder—Mesalazine—Crohn's disease	0.00265	0.00273	CcSEcCtD
Methylphenidate—Chills—Azathioprine—Crohn's disease	0.00264	0.00272	CcSEcCtD
Methylphenidate—Connective tissue disorder—Mesalazine—Crohn's disease	0.00264	0.00271	CcSEcCtD
Methylphenidate—Arrhythmia—Azathioprine—Crohn's disease	0.00263	0.00271	CcSEcCtD
Methylphenidate—Urethral disorder—Mesalazine—Crohn's disease	0.00263	0.00271	CcSEcCtD
Methylphenidate—Alopecia—Azathioprine—Crohn's disease	0.0026	0.00268	CcSEcCtD
Methylphenidate—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00259	0.00266	CcSEcCtD
Methylphenidate—Ecchymosis—Prednisone—Crohn's disease	0.00256	0.00263	CcSEcCtD
Methylphenidate—Erythema multiforme—Mesalazine—Crohn's disease	0.00254	0.00261	CcSEcCtD
Methylphenidate—Eye disorder—Mesalazine—Crohn's disease	0.00251	0.00258	CcSEcCtD
Methylphenidate—Cardiac disorder—Mesalazine—Crohn's disease	0.00249	0.00256	CcSEcCtD
Methylphenidate—Hyperkinesia—Prednisone—Crohn's disease	0.00247	0.00254	CcSEcCtD
Methylphenidate—Angiopathy—Mesalazine—Crohn's disease	0.00244	0.0025	CcSEcCtD
Methylphenidate—Euphoric mood—Prednisone—Crohn's disease	0.00243	0.0025	CcSEcCtD
Methylphenidate—Immune system disorder—Mesalazine—Crohn's disease	0.00242	0.00249	CcSEcCtD
Methylphenidate—Mediastinal disorder—Mesalazine—Crohn's disease	0.00242	0.00249	CcSEcCtD
Methylphenidate—Chills—Mesalazine—Crohn's disease	0.00241	0.00248	CcSEcCtD
Methylphenidate—Diarrhoea—Mercaptopurine—Crohn's disease	0.0024	0.00247	CcSEcCtD
Methylphenidate—Ill-defined disorder—Azathioprine—Crohn's disease	0.00238	0.00245	CcSEcCtD
Methylphenidate—Alopecia—Mesalazine—Crohn's disease	0.00237	0.00244	CcSEcCtD
Methylphenidate—Anaemia—Azathioprine—Crohn's disease	0.00237	0.00244	CcSEcCtD
Methylphenidate—Diabetes mellitus—Prednisone—Crohn's disease	0.00236	0.00243	CcSEcCtD
Methylphenidate—Mental disorder—Mesalazine—Crohn's disease	0.00235	0.00242	CcSEcCtD
Methylphenidate—Erythema—Mesalazine—Crohn's disease	0.00234	0.0024	CcSEcCtD
Methylphenidate—Malaise—Azathioprine—Crohn's disease	0.00231	0.00238	CcSEcCtD
Methylphenidate—Leukopenia—Azathioprine—Crohn's disease	0.0023	0.00236	CcSEcCtD
Methylphenidate—Tension—Mesalazine—Crohn's disease	0.00229	0.00236	CcSEcCtD
Methylphenidate—Nervousness—Mesalazine—Crohn's disease	0.00227	0.00233	CcSEcCtD
Methylphenidate—Back pain—Mesalazine—Crohn's disease	0.00226	0.00232	CcSEcCtD
Methylphenidate—Muscle spasms—Mesalazine—Crohn's disease	0.00225	0.00231	CcSEcCtD
Methylphenidate—Vomiting—Mercaptopurine—Crohn's disease	0.00223	0.0023	CcSEcCtD
Methylphenidate—Injury—Prednisone—Crohn's disease	0.00223	0.0023	CcSEcCtD
Methylphenidate—Rash—Mercaptopurine—Crohn's disease	0.00222	0.00228	CcSEcCtD
Methylphenidate—Dermatitis—Mercaptopurine—Crohn's disease	0.00221	0.00228	CcSEcCtD
Methylphenidate—Vision blurred—Mesalazine—Crohn's disease	0.0022	0.00226	CcSEcCtD
Methylphenidate—Tremor—Mesalazine—Crohn's disease	0.00219	0.00225	CcSEcCtD
Methylphenidate—Increased appetite—Prednisone—Crohn's disease	0.00219	0.00225	CcSEcCtD
Methylphenidate—Arthralgia—Azathioprine—Crohn's disease	0.00218	0.00225	CcSEcCtD
Methylphenidate—Myalgia—Azathioprine—Crohn's disease	0.00218	0.00225	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00217	0.00223	CcSEcCtD
Methylphenidate—Ill-defined disorder—Mesalazine—Crohn's disease	0.00217	0.00223	CcSEcCtD
Methylphenidate—Anaemia—Mesalazine—Crohn's disease	0.00216	0.00222	CcSEcCtD
Methylphenidate—Discomfort—Azathioprine—Crohn's disease	0.00216	0.00222	CcSEcCtD
Methylphenidate—Angioedema—Mesalazine—Crohn's disease	0.00214	0.0022	CcSEcCtD
Methylphenidate—Malaise—Mesalazine—Crohn's disease	0.00211	0.00217	CcSEcCtD
Methylphenidate—Vertigo—Mesalazine—Crohn's disease	0.0021	0.00216	CcSEcCtD
Methylphenidate—Syncope—Mesalazine—Crohn's disease	0.0021	0.00215	CcSEcCtD
Methylphenidate—Lethargy—Prednisone—Crohn's disease	0.00209	0.00215	CcSEcCtD
Methylphenidate—Leukopenia—Mesalazine—Crohn's disease	0.00209	0.00215	CcSEcCtD
Methylphenidate—Nausea—Mercaptopurine—Crohn's disease	0.00209	0.00215	CcSEcCtD
Methylphenidate—Infection—Azathioprine—Crohn's disease	0.00208	0.00214	CcSEcCtD
Methylphenidate—Palpitations—Mesalazine—Crohn's disease	0.00206	0.00212	CcSEcCtD
Methylphenidate—Loss of consciousness—Mesalazine—Crohn's disease	0.00205	0.00211	CcSEcCtD
Methylphenidate—Thrombocytopenia—Azathioprine—Crohn's disease	0.00205	0.00211	CcSEcCtD
Methylphenidate—Cough—Mesalazine—Crohn's disease	0.00204	0.0021	CcSEcCtD
Methylphenidate—Skin disorder—Azathioprine—Crohn's disease	0.00203	0.00209	CcSEcCtD
Methylphenidate—Affect lability—Prednisone—Crohn's disease	0.00202	0.00208	CcSEcCtD
Methylphenidate—Hypertension—Mesalazine—Crohn's disease	0.00202	0.00207	CcSEcCtD
Methylphenidate—Psychotic disorder—Prednisone—Crohn's disease	0.002	0.00206	CcSEcCtD
Methylphenidate—Chest pain—Mesalazine—Crohn's disease	0.00199	0.00205	CcSEcCtD
Methylphenidate—Arthralgia—Mesalazine—Crohn's disease	0.00199	0.00205	CcSEcCtD
Methylphenidate—Myalgia—Mesalazine—Crohn's disease	0.00199	0.00205	CcSEcCtD
Methylphenidate—Anxiety—Mesalazine—Crohn's disease	0.00198	0.00204	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00198	0.00203	CcSEcCtD
Methylphenidate—Discomfort—Mesalazine—Crohn's disease	0.00197	0.00202	CcSEcCtD
Methylphenidate—Irritability—Prednisone—Crohn's disease	0.00196	0.00201	CcSEcCtD
Methylphenidate—Cardiac arrest—Prednisone—Crohn's disease	0.00195	0.00201	CcSEcCtD
Methylphenidate—Dry mouth—Mesalazine—Crohn's disease	0.00195	0.002	CcSEcCtD
Methylphenidate—Mood swings—Prednisone—Crohn's disease	0.00194	0.002	CcSEcCtD
Methylphenidate—Confusional state—Mesalazine—Crohn's disease	0.00192	0.00198	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00191	0.00196	CcSEcCtD
Methylphenidate—Anaphylactic shock—Mesalazine—Crohn's disease	0.00191	0.00196	CcSEcCtD
Methylphenidate—Oedema—Mesalazine—Crohn's disease	0.00191	0.00196	CcSEcCtD
Methylphenidate—Infection—Mesalazine—Crohn's disease	0.00189	0.00195	CcSEcCtD
Methylphenidate—Shock—Mesalazine—Crohn's disease	0.00188	0.00193	CcSEcCtD
Methylphenidate—Nervous system disorder—Mesalazine—Crohn's disease	0.00187	0.00192	CcSEcCtD
Methylphenidate—Thrombocytopenia—Mesalazine—Crohn's disease	0.00187	0.00192	CcSEcCtD
Methylphenidate—Tachycardia—Mesalazine—Crohn's disease	0.00186	0.00191	CcSEcCtD
Methylphenidate—Skin disorder—Mesalazine—Crohn's disease	0.00185	0.0019	CcSEcCtD
Methylphenidate—Hyperhidrosis—Mesalazine—Crohn's disease	0.00184	0.0019	CcSEcCtD
Methylphenidate—Anorexia—Mesalazine—Crohn's disease	0.00182	0.00187	CcSEcCtD
Methylphenidate—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00181	0.00186	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00181	0.00186	CcSEcCtD
Methylphenidate—Pancreatitis—Prednisone—Crohn's disease	0.00174	0.00179	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00174	0.00179	CcSEcCtD
Methylphenidate—Feeling abnormal—Azathioprine—Crohn's disease	0.00173	0.00177	CcSEcCtD
Methylphenidate—Insomnia—Mesalazine—Crohn's disease	0.00172	0.00177	CcSEcCtD
Methylphenidate—Paraesthesia—Mesalazine—Crohn's disease	0.00171	0.00176	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00171	0.00176	CcSEcCtD
Methylphenidate—Dyspnoea—Mesalazine—Crohn's disease	0.0017	0.00175	CcSEcCtD
Methylphenidate—Somnolence—Mesalazine—Crohn's disease	0.0017	0.00174	CcSEcCtD
Methylphenidate—Dyspepsia—Mesalazine—Crohn's disease	0.00168	0.00173	CcSEcCtD
Methylphenidate—Decreased appetite—Mesalazine—Crohn's disease	0.00166	0.0017	CcSEcCtD
Methylphenidate—Body temperature increased—Azathioprine—Crohn's disease	0.00166	0.0017	CcSEcCtD
Methylphenidate—Abdominal pain—Azathioprine—Crohn's disease	0.00166	0.0017	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00165	0.00169	CcSEcCtD
Methylphenidate—Fatigue—Mesalazine—Crohn's disease	0.00164	0.00169	CcSEcCtD
Methylphenidate—Erectile dysfunction—Prednisone—Crohn's disease	0.00163	0.00168	CcSEcCtD
Methylphenidate—Pain—Mesalazine—Crohn's disease	0.00163	0.00168	CcSEcCtD
Methylphenidate—Constipation—Mesalazine—Crohn's disease	0.00163	0.00168	CcSEcCtD
Methylphenidate—Weight increased—Prednisone—Crohn's disease	0.00161	0.00166	CcSEcCtD
Methylphenidate—Weight decreased—Prednisone—Crohn's disease	0.00161	0.00165	CcSEcCtD
Methylphenidate—Depression—Prednisone—Crohn's disease	0.00158	0.00162	CcSEcCtD
Methylphenidate—Feeling abnormal—Mesalazine—Crohn's disease	0.00157	0.00162	CcSEcCtD
Methylphenidate—Acute coronary syndrome—Prednisone—Crohn's disease	0.00156	0.0016	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00156	0.0016	CcSEcCtD
Methylphenidate—Myocardial infarction—Prednisone—Crohn's disease	0.00155	0.00159	CcSEcCtD
Methylphenidate—Hypersensitivity—Azathioprine—Crohn's disease	0.00154	0.00159	CcSEcCtD
Methylphenidate—Urticaria—Mesalazine—Crohn's disease	0.00151	0.00156	CcSEcCtD
Methylphenidate—Body temperature increased—Mesalazine—Crohn's disease	0.00151	0.00155	CcSEcCtD
Methylphenidate—Abdominal pain—Mesalazine—Crohn's disease	0.00151	0.00155	CcSEcCtD
Methylphenidate—Bradycardia—Prednisone—Crohn's disease	0.00145	0.00149	CcSEcCtD
Methylphenidate—Diarrhoea—Azathioprine—Crohn's disease	0.00143	0.00147	CcSEcCtD
Methylphenidate—Haemoglobin—Prednisone—Crohn's disease	0.00143	0.00147	CcSEcCtD
Methylphenidate—Haemorrhage—Prednisone—Crohn's disease	0.00142	0.00146	CcSEcCtD
Methylphenidate—Hallucination—Prednisone—Crohn's disease	0.00141	0.00145	CcSEcCtD
Methylphenidate—Hypersensitivity—Mesalazine—Crohn's disease	0.00141	0.00144	CcSEcCtD
Methylphenidate—Connective tissue disorder—Prednisone—Crohn's disease	0.0014	0.00144	CcSEcCtD
Methylphenidate—Dizziness—Azathioprine—Crohn's disease	0.00138	0.00142	CcSEcCtD
Methylphenidate—Asthenia—Mesalazine—Crohn's disease	0.00137	0.00141	CcSEcCtD
Methylphenidate—Pruritus—Mesalazine—Crohn's disease	0.00135	0.00139	CcSEcCtD
Methylphenidate—Vomiting—Azathioprine—Crohn's disease	0.00133	0.00137	CcSEcCtD
Methylphenidate—Eye disorder—Prednisone—Crohn's disease	0.00133	0.00136	CcSEcCtD
Methylphenidate—Rash—Azathioprine—Crohn's disease	0.00132	0.00136	CcSEcCtD
Methylphenidate—Dermatitis—Azathioprine—Crohn's disease	0.00132	0.00136	CcSEcCtD
Methylphenidate—Flushing—Prednisone—Crohn's disease	0.00132	0.00136	CcSEcCtD
Methylphenidate—Headache—Azathioprine—Crohn's disease	0.00131	0.00135	CcSEcCtD
Methylphenidate—Diarrhoea—Mesalazine—Crohn's disease	0.0013	0.00134	CcSEcCtD
Methylphenidate—Angiopathy—Prednisone—Crohn's disease	0.00129	0.00132	CcSEcCtD
Methylphenidate—Immune system disorder—Prednisone—Crohn's disease	0.00128	0.00132	CcSEcCtD
Methylphenidate—Arrhythmia—Prednisone—Crohn's disease	0.00127	0.0013	CcSEcCtD
Methylphenidate—Dizziness—Mesalazine—Crohn's disease	0.00126	0.0013	CcSEcCtD
Methylphenidate—Alopecia—Prednisone—Crohn's disease	0.00125	0.00129	CcSEcCtD
Methylphenidate—Mental disorder—Prednisone—Crohn's disease	0.00124	0.00128	CcSEcCtD
Methylphenidate—Nausea—Azathioprine—Crohn's disease	0.00124	0.00128	CcSEcCtD
Methylphenidate—Malnutrition—Prednisone—Crohn's disease	0.00124	0.00127	CcSEcCtD
Methylphenidate—Erythema—Prednisone—Crohn's disease	0.00124	0.00127	CcSEcCtD
Methylphenidate—Vomiting—Mesalazine—Crohn's disease	0.00121	0.00125	CcSEcCtD
Methylphenidate—Rash—Mesalazine—Crohn's disease	0.0012	0.00124	CcSEcCtD
Methylphenidate—Dermatitis—Mesalazine—Crohn's disease	0.0012	0.00124	CcSEcCtD
Methylphenidate—Headache—Mesalazine—Crohn's disease	0.00119	0.00123	CcSEcCtD
Methylphenidate—Vision blurred—Prednisone—Crohn's disease	0.00117	0.0012	CcSEcCtD
Methylphenidate—Ill-defined disorder—Prednisone—Crohn's disease	0.00115	0.00118	CcSEcCtD
Methylphenidate—Anaemia—Prednisone—Crohn's disease	0.00114	0.00117	CcSEcCtD
Methylphenidate—Agitation—Prednisone—Crohn's disease	0.00114	0.00117	CcSEcCtD
Methylphenidate—Nausea—Mesalazine—Crohn's disease	0.00113	0.00116	CcSEcCtD
Methylphenidate—Angioedema—Prednisone—Crohn's disease	0.00113	0.00116	CcSEcCtD
Methylphenidate—Malaise—Prednisone—Crohn's disease	0.00111	0.00115	CcSEcCtD
Methylphenidate—Vertigo—Prednisone—Crohn's disease	0.00111	0.00114	CcSEcCtD
Methylphenidate—Syncope—Prednisone—Crohn's disease	0.00111	0.00114	CcSEcCtD
Methylphenidate—Loss of consciousness—Prednisone—Crohn's disease	0.00109	0.00112	CcSEcCtD
Methylphenidate—Convulsion—Prednisone—Crohn's disease	0.00107	0.0011	CcSEcCtD
Methylphenidate—Hypertension—Prednisone—Crohn's disease	0.00107	0.0011	CcSEcCtD
Methylphenidate—Myalgia—Prednisone—Crohn's disease	0.00105	0.00108	CcSEcCtD
Methylphenidate—Arthralgia—Prednisone—Crohn's disease	0.00105	0.00108	CcSEcCtD
Methylphenidate—Anxiety—Prednisone—Crohn's disease	0.00105	0.00108	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00105	0.00107	CcSEcCtD
Methylphenidate—Discomfort—Prednisone—Crohn's disease	0.00104	0.00107	CcSEcCtD
Methylphenidate—Anaphylactic shock—Prednisone—Crohn's disease	0.00101	0.00104	CcSEcCtD
Methylphenidate—Oedema—Prednisone—Crohn's disease	0.00101	0.00104	CcSEcCtD
Methylphenidate—Infection—Prednisone—Crohn's disease	0.001	0.00103	CcSEcCtD
Methylphenidate—Shock—Prednisone—Crohn's disease	0.000993	0.00102	CcSEcCtD
Methylphenidate—Nervous system disorder—Prednisone—Crohn's disease	0.000989	0.00102	CcSEcCtD
Methylphenidate—Tachycardia—Prednisone—Crohn's disease	0.000985	0.00101	CcSEcCtD
Methylphenidate—Skin disorder—Prednisone—Crohn's disease	0.00098	0.00101	CcSEcCtD
Methylphenidate—Hyperhidrosis—Prednisone—Crohn's disease	0.000975	0.001	CcSEcCtD
Methylphenidate—Anorexia—Prednisone—Crohn's disease	0.000962	0.000989	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000919	0.000945	CcSEcCtD
Methylphenidate—Insomnia—Prednisone—Crohn's disease	0.000913	0.000938	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisone—Crohn's disease	0.000906	0.000932	CcSEcCtD
Methylphenidate—Dyspepsia—Prednisone—Crohn's disease	0.000888	0.000913	CcSEcCtD
Methylphenidate—Decreased appetite—Prednisone—Crohn's disease	0.000877	0.000902	CcSEcCtD
Methylphenidate—Fatigue—Prednisone—Crohn's disease	0.00087	0.000894	CcSEcCtD
Methylphenidate—Constipation—Prednisone—Crohn's disease	0.000863	0.000887	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisone—Crohn's disease	0.000831	0.000855	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Prednisone—Crohn's disease	0.000825	0.000848	CcSEcCtD
Methylphenidate—Urticaria—Prednisone—Crohn's disease	0.000802	0.000824	CcSEcCtD
Methylphenidate—Body temperature increased—Prednisone—Crohn's disease	0.000798	0.00082	CcSEcCtD
Methylphenidate—Abdominal pain—Prednisone—Crohn's disease	0.000798	0.00082	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisone—Crohn's disease	0.000743	0.000764	CcSEcCtD
Methylphenidate—Asthenia—Prednisone—Crohn's disease	0.000724	0.000744	CcSEcCtD
Methylphenidate—Pruritus—Prednisone—Crohn's disease	0.000714	0.000734	CcSEcCtD
Methylphenidate—Diarrhoea—Prednisone—Crohn's disease	0.00069	0.00071	CcSEcCtD
Methylphenidate—Dizziness—Prednisone—Crohn's disease	0.000667	0.000686	CcSEcCtD
Methylphenidate—Vomiting—Prednisone—Crohn's disease	0.000642	0.00066	CcSEcCtD
Methylphenidate—Rash—Prednisone—Crohn's disease	0.000636	0.000654	CcSEcCtD
Methylphenidate—Dermatitis—Prednisone—Crohn's disease	0.000636	0.000654	CcSEcCtD
Methylphenidate—Headache—Prednisone—Crohn's disease	0.000632	0.00065	CcSEcCtD
Methylphenidate—Nausea—Prednisone—Crohn's disease	0.000599	0.000616	CcSEcCtD
